Market Overview:
The global blood group typing technology market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for blood group typing technology in the clinical laboratories, hospitals, and blood banks applications. Additionally, the increasing prevalence of transfusion-transmitted diseases and rising number of accidents and surgeries are also contributing to the growth of this market. The PCR-based techniques segment is expected to dominate the global blood group typing technology market during the forecast period owing to its high accuracy and speed as compared to other techniques.
Product Definition:
Blood group typing technology is used to determine the blood group of a person. The importance of blood group typing technology is that it can help to prevent the transfusion of incompatible blood types and save lives.
PCR-Based and Microarray Techniques:
Polymerase Chain Reaction (PCR) is a technique that uses DNA as a probe to identify and amplify specific genetic sequences. The technology was developed in the early 1980s by Kary B. Mullis, who was awarded the 2001 Nobel Prize in Chemistry for his work on this subject. PCR-based techniques are used for various applications such as gene expression analysis, genotyping, mutation detection, and forensic science among others.
Assay-Based Techniques:
The global assay-based techniques and it's usage in blood group typing technology market size was valued at USD 0.5 billion in 2015. The increasing demand for rapid, accurate, and sensitive SBR based tests that can be used on the point of care is expected to drive growth over the forecast period.
Application Insights:
Based on application, the global blood group typing technology market is segmented into clinical laboratories, hospitals and blood banks. Hospitals are anticipated to be the fastest growing segment owing to an increase in patient admissions due to COVID-19 pandemic. As of September 2018, over 1 million people have been reported infected with COVID-19 across the world. Thus an increase in patient admissions will boost demand for blood group typing techniques at hospital level which in turn is expected to drive growth over next few years.
Blood type antigens are also found on red cells and plasma proteins; therefore these two types of cells can be used as a source of antibodies against them (type specific antibodies). These type specific antibodies can then be used for detecting other related products such as RBCs or PRP using immunoassays or mass spectroscopy techniques respectively.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of blood group typing technology providers and high adoption rate for advanced diagnostic techniques. The U.S., which is at the forefront, has one of the highest per capita income levels coupled with a developed healthcare system that makes use of advanced technologies for disease management & prevention.
Asia Pacific is expected to register significant growth over the forecast period owing to factors such as improving healthcare infrastructure, rising awareness about blood group typing technology among patients, and an increase in medical tourism activities due to availability of affordable treatments in countries like China & India as compared to western countries.
Growth Factors:
- Increasing demand for blood transfusion and organ transplantation surgeries
- Rising prevalence of blood disorders and genetic diseases
- Technological advancements in blood group typing methods
- Growing awareness about the benefits of blood group typing technology
- Increasing funding for research and development in this field
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Group Typing Technology Market Research Report
By Type
PCR-Based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing
By Application
Clinical Laboratories, Hospitals, Blood Banks
By Companies
Bio-Rad Laboratories, Inc, Merck Millipore, Ortho Clinical Diagnostics, Danaher Corporation, Grifols, S.A, Immucor, Inc, Quotient, Ltd, Bag Health Care GmbH, Agena Bioscience, Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Blood Group Typing Technology Market Report Segments:
The global Blood Group Typing Technology market is segmented on the basis of:
Types
PCR-Based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Laboratories, Hospitals, Blood Banks
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad Laboratories, Inc
- Merck Millipore
- Ortho Clinical Diagnostics
- Danaher Corporation
- Grifols, S.A
- Immucor, Inc
- Quotient, Ltd
- Bag Health Care GmbH
- Agena Bioscience, Inc
Highlights of The Blood Group Typing Technology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PCR-Based and Microarray Techniques
- Assay-Based Techniques
- Massively Parallel Sequencing
- By Application:
- Clinical Laboratories
- Hospitals
- Blood Banks
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Group Typing Technology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood group typing technology is a laboratory procedure that uses antibodies to identify the blood groups of individuals.
Some of the major companies in the blood group typing technology market are Bio-Rad Laboratories, Inc, Merck Millipore, Ortho Clinical Diagnostics, Danaher Corporation, Grifols, S.A, Immucor, Inc, Quotient, Ltd, Bag Health Care GmbH, Agena Bioscience, Inc.
The blood group typing technology market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Group Typing Technology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blood Group Typing Technology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blood Group Typing Technology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blood Group Typing Technology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blood Group Typing Technology Market Size & Forecast, 2020-2028
4.5.1 Blood Group Typing Technology Market Size and Y-o-Y Growth
4.5.2 Blood Group Typing Technology Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 PCR-Based and Microarray Techniques
5.2.2 Assay-Based Techniques
5.2.3 Massively Parallel Sequencing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinical Laboratories
6.2.2 Hospitals
6.2.3 Blood Banks
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Group Typing Technology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Group Typing Technology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 PCR-Based and Microarray Techniques
9.6.2 Assay-Based Techniques
9.6.3 Massively Parallel Sequencing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinical Laboratories
9.10.2 Hospitals
9.10.3 Blood Banks
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 PCR-Based and Microarray Techniques
10.6.2 Assay-Based Techniques
10.6.3 Massively Parallel Sequencing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinical Laboratories
10.10.2 Hospitals
10.10.3 Blood Banks
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 PCR-Based and Microarray Techniques
11.6.2 Assay-Based Techniques
11.6.3 Massively Parallel Sequencing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinical Laboratories
11.10.2 Hospitals
11.10.3 Blood Banks
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 PCR-Based and Microarray Techniques
12.6.2 Assay-Based Techniques
12.6.3 Massively Parallel Sequencing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinical Laboratories
12.10.2 Hospitals
12.10.3 Blood Banks
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 PCR-Based and Microarray Techniques
13.6.2 Assay-Based Techniques
13.6.3 Massively Parallel Sequencing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinical Laboratories
13.10.2 Hospitals
13.10.3 Blood Banks
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Group Typing Technology Market: Competitive Dashboard
14.2 Global Blood Group Typing Technology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad Laboratories, Inc
14.3.2 Merck Millipore
14.3.3 Ortho Clinical Diagnostics
14.3.4 Danaher Corporation
14.3.5 Grifols, S.A
14.3.6 Immucor, Inc
14.3.7 Quotient, Ltd
14.3.8 Bag Health Care GmbH
14.3.9 Agena Bioscience, Inc
